Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

118.8K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.8K
Depression: Overview01:18

Depression: Overview

244
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
244
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

102
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
102
Human Genetics01:28

Human Genetics

569
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
569
Long-term Depression01:03

Long-term Depression

2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice.

The international journal of neuropsychopharmacology·2023
Same author

S-Cu-FC/CuS modified GO carboxymethyl cellulose hydrogel for enhanced photocatalytic sterilization through homo-heterojunction interface accelerated charge transfer.

Biomaterials science·2023
Same author

<i>ntrC</i> Contributes to Nitrogen Utilization, Stress Tolerance, and Virulence in <i>Acidovorax citrulli</i>.

Microorganisms·2023
Same author

Construction of 3-Oxazolin-5-one via Visible Light-Induced Nondecarboxylative Coupling and Sequential Reactions.

Organic letters·2023
Same author

Identification of predictive factors for outcomes after robot-assisted partial nephrectomy based on three-dimensional reconstruction of preoperative enhanced computerized tomography.

Frontiers in oncology·2023
Same author

Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1-2M1 renal cell carcinoma.

Translational cancer research·2023
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2025

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K

Progress in the relationship between GDF11 and depression.

Xiang Jin1, Wei Guan2

  • 1Department of Pharmacy, The Second People's Hospital of Nantong, Nantong, China.

Life Sciences
|February 20, 2024
PubMed
Summary
This summary is machine-generated.

Growth differentiation factor 11 (GDF11), an anti-aging molecule, shows potential in treating depression by enhancing neurogenesis and neuronal activity. Further research into GDF11 mechanisms may lead to novel depression therapies.

Keywords:
AntidepressantDepressionGDF11HippocampusTargets

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

52
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

37.3K

Related Experiment Videos

Last Updated: Jul 2, 2025

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

52
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

37.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Depression morbidity is increasing, particularly in younger populations, driven by complex genetic and environmental factors.
  • Current antidepressant therapies offer limited efficacy and significant side effects, necessitating the exploration of new therapeutic targets.
  • Growth differentiation factor 11 (GDF11), a member of the transforming growth factor β superfamily, is recognized for its anti-aging properties.

Purpose of the Study:

  • To review the role and mechanistic pathways of GDF11 in the pathogenesis of depression.
  • To explore GDF11 as a potential therapeutic target for novel depression treatments.

Main Methods:

  • Literature review of existing studies on GDF11 and depression.
  • Analysis of GDF11's molecular functions, including neurogenesis and neuronal activity.
  • Discussion of potential therapeutic applications of GDF11 in depression.

Main Results:

  • GDF11 has been shown to positively regulate neurogenesis and enhance neuronal activity.
  • These effects of GDF11 suggest a potential role in attenuating depression-like behaviors.
  • While GDF11's functions in other diseases are studied, its specific mechanisms in depression require further elucidation.

Conclusions:

  • GDF11 presents a promising avenue for developing novel depression therapies.
  • Understanding GDF11's mechanistic pathways in depression is crucial for its therapeutic application.
  • Targeting GDF11 could offer a new strategy to combat the rising prevalence of depression.